| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 883-894, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
ER O'Brien, MR Garvin, R Dev, DK Stewart, T Hinohara, JB Simpson and SM Schwartz
Department of Pathology, University of Washington School of Medicine, Seattle.
Neovascularization in the walls of coronary arteries is associated with the presence of atherosclerotic plaque. The mechanisms responsible for the formation of these intraplaque microvessels are not understood. The purpose of this study is to examine the prevalence of endothelial cell replication in plaque microvessels. Two hundred and one primary and restenotic coronary atherectomy specimens were analyzed for the presence of microvessels and proliferation as reflected by positive immunolabeling for Ulex agglutinin and the proliferating cell nuclear antigen, respectively. In primary but not restenotic specimens, proliferation of any cell type was associated with the detection of microvessels on the same slide. However, intraplaque microvessels were more commonly found in restenotic compared to primary specimens (P = 0.004). Twelve highly vascularized specimens with evidence of replication were subjected to detailed histomorphological and quantitative image analyses. At 200 x, the most vascular optical field of each slide was identified and consistently included plaque macrophages. Total slide endothelial cell replication indices for these specimens varied, but in some instances were remarkably elevated (eg, 43.5%). The role of intraplaque angiogenesis may be analogous to that of tumor or wound angiogenesis and be important in development and progression of coronary artery lesions and restenosis.
This article has been cited by other articles:
![]() |
S. Y. Cheranov, M. Karpurapu, D. Wang, B. Zhang, R. C. Venema, and G. N. Rao An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis Blood, June 15, 2008; 111(12): 5581 - 5591. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Kalka and I. Baumgartner Gene and stem cell therapy in peripheral arterial occlusive disease Vascular Medicine, May 1, 2008; 13(2): 157 - 172. [Abstract] [PDF] |
||||
![]() |
K. A. Horvath and Y. Zhou Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752. [Full Text] |
||||
![]() |
A. Choudhury, B. Freestone, J. Patel, and G. Y. H. Lip Relationship of Soluble CD40 Ligand to Vascular Endothelial Growth Factor, Angiopoietins, and Tissue Factor in Atrial Fibrillation: A Link Among Platelet Activation, Angiogenesis, and Thrombosis? Chest, December 1, 2007; 132(6): 1913 - 1919. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. N. Bochkov, M. Philippova, O. Oskolkova, A. Kadl, A. Furnkranz, E. Karabeg, T. Afonyushkin, F. Gruber, J. Breuss, A. Minchenko, et al. Oxidized Phospholipids Stimulate Angiogenesis Via Autocrine Mechanisms, Implicating a Novel Role for Lipid Oxidation in the Evolution of Atherosclerotic Lesions Circ. Res., October 13, 2006; 99(8): 900 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Y. Chen, B.-C. Cheng, M.-J. Jiang, M.-Y. Hsieh, and M.-S. Chang IL-20 Is Expressed in Atherosclerosis Plaques and Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2090 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Winter, A. M. Neubauer, S. D. Caruthers, T. D. Harris, J. D. Robertson, T. A. Williams, A. H. Schmieder, G. Hu, J. S. Allen, E. K. Lacy, et al. Endothelial {alpha}{nu}{beta}3 Integrin-Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2103 - 2109. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fujita, M. Yoshizumi, Y. Izawa, N. Ali, H. Ohnishi, Y. Kanematsu, K. Ishizawa, K. Tsuchiya, and T. Tamaki Transactivation of Fetal Liver Kinase-1/Kinase-Insert Domain-Containing Receptor by Lysophosphatidylcholine Induces Vascular Endothelial Cell Proliferation Endocrinology, March 1, 2006; 147(3): 1377 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Iribarren, L. J Herrinton, J. A Darbinian, L. Tamarkin, D. Malinowski, J. H Vogelman, N. Orentreich, and D. Baer Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race? Vascular Medicine, February 1, 2006; 11(1): 13 - 20. [Abstract] [PDF] |
||||
![]() |
B. Zhang, H. Cao, and G. N. Rao Fibroblast Growth Factor-2 Is a Downstream Mediator of Phosphatidylinositol 3-Kinase-Akt Signaling in 14,15-Epoxyeicosatrienoic Acid-induced Angiogenesis J. Biol. Chem., January 13, 2006; 281(2): 905 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Virmani, F. D. Kolodgie, A. P. Burke, A. V. Finn, H. K. Gold, T. N. Tulenko, S. P. Wrenn, and J. Narula Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2054 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Khurana, M. Simons, J. F. Martin, and I. C. Zachary Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal Circulation, September 20, 2005; 112(12): 1813 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, H. Cao, and G. N. Rao 15(S)-Hydroxyeicosatetraenoic Acid Induces Angiogenesis via Activation of PI3K-Akt-mTOR-S6K1 Signaling Cancer Res., August 15, 2005; 65(16): 7283 - 7291. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Simons Angiogenesis: Where Do We Stand Now? Circulation, March 29, 2005; 111(12): 1556 - 1566. [Full Text] [PDF] |
||||
![]() |
I. Shiojima and K. Walsh The Role of Vascular Endothelial Growth Factor in Restenosis: The Controversy Continues Circulation, October 19, 2004; 110(16): 2283 - 2286. [Full Text] [PDF] |
||||
![]() |
K. S. Moulton, B. R. Olsen, S. Sonn, N. Fukai, D. Zurakowski, and X. Zeng Loss of Collagen XVIII Enhances Neovascularization and Vascular Permeability in Atherosclerosis Circulation, September 7, 2004; 110(10): 1330 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D Blann Angiogenesis and platelets: the clot thickens further Cardiovasc Res, August 1, 2004; 63(2): 192 - 193. [Full Text] [PDF] |
||||
![]() |
C. Calvi, P. Dentelli, M. Pagano, A. Rosso, M. Pegoraro, S. Giunti, G. Garbarino, G. Camussi, L. Pegoraro, and M. F. Brizzi Angiopoietin 2 Induces Cell Cycle Arrest in Endothelial Cells: A Possible Mechanism Involved in Advanced Plaque Neovascularization Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 511 - 518. [Abstract] [Full Text] |
||||
![]() |
C. R. W. Kuhlmann, M. Schafer, F. Li, T. Sawamura, H. Tillmanns, B. Waldecker, and J. Wiecha Modulation of endothelial Ca2+-activated K+ channels by oxidized LDL and its contribution to endothelial proliferation Cardiovasc Res, December 1, 2003; 60(3): 626 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Winter, A. M. Morawski, S. D. Caruthers, R. W. Fuhrhop, H. Zhang, T. A. Williams, J. S. Allen, E. K. Lacy, J. D. Robertson, G. M. Lanza, et al. Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With {alpha}v{beta}3-Integrin-Targeted Nanoparticles Circulation, November 4, 2003; 108(18): 2270 - 2274. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass Angiogenesis in Endocrine Tumors Endocr. Rev., October 1, 2003; 24(5): 600 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V Baklanov, K. G Peters, A. L Seidel, D. A Taylor, and B. H Annex Neovascularization in intimal hyperplasia is associated with vein graft failure after coronary artery bypass surgery Vascular Medicine, August 1, 2003; 8(3): 163 - 167. [Abstract] [PDF] |
||||
![]() |
K. S. Moulton, K. Vakili, D. Zurakowski, M. Soliman, C. Butterfield, E. Sylvin, K.-M. Lo, S. Gillies, K. Javaherian, and J. Folkman Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis PNAS, April 15, 2003; 100(8): 4736 - 4741. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Sellke and M. Ruel Vascular growth factors and angiogenesis in cardiac surgery Ann. Thorac. Surg., February 1, 2003; 75(2): S685 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text] |
||||
![]() |
Z.-Z. Zeng, C. R. Yellaturu, I. Neeli, and G. N. Rao 5(S)-Hydroxyeicosatetraenoic Acid Stimulates DNA Synthesis in Human Microvascular Endothelial Cells via Activation of Jak/STAT and Phosphatidylinositol 3-Kinase/Akt Signaling, Leading to Induction of Expression of Basic Fibroblast Growth Factor 2 J. Biol. Chem., October 18, 2002; 277(43): 41213 - 41219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruel, R. J. Laham, J. A. Parker, M. J. Post, J. A. Ware, M. Simons, and F. W. Sellke Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Hunt, R. Fairman, M. E. Mitchell, J. P. Carpenter, M. Golden, T. Khalapyan, M. Wolfe, D. Neschis, R. Milner, B. Scoll, et al. Bone Formation in Carotid Plaques: A Clinicopathological Study Stroke, May 1, 2002; 33(5): 1214 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vincent, C. Soria, F. Mirshahi, P. Opolon, Z. Mishal, J.-P. Vannier, J. Soria, and L. Hong Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 623 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cieslak, J. Niewiarowska, M. Nawrot, M. Koziolkiewicz, W. J. Stec, and C. S. Cierniewski DNAzymes to beta 1 and beta 3 mRNA Down-regulate Expression of the Targeted Integrins and Inhibit Endothelial Cell Capillary Tube Formation in Fibrin and Matrigel J. Biol. Chem., February 22, 2002; 277(9): 6779 - 6787. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Epstein, R. Kornowski, S. Fuchs, and H. F. Dvorak Angiogenesis Therapy : Amidst the Hype, the Neglected Potential for Serious Side Effects Circulation, July 3, 2001; 104(1): 115 - 119. [Full Text] [PDF] |
||||
![]() |
G. G. Bishop, J. A. McPherson, J. M. Sanders, S. E. Hesselbacher, M. J. Feldman, C. A. McNamara, L. W. Gimple, E. R. Powers, S. A. Mousa, and I. J. Sarembock Selective {{alpha}}v{beta}3-Receptor Blockade Reduces Macrophage Infiltration and Restenosis After Balloon Angioplasty in the Atherosclerotic Rabbit Circulation, April 10, 2001; 103(14): 1906 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Epstein, S. Fuchs, Y. F. Zhou, R. Baffour, and R. Kornowski Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards Cardiovasc Res, February 16, 2001; 49(3): 532 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. van Royen, J. J. Piek, I. Buschmann, I. Hoefer, M. Voskuil, and W. Schaper Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease Cardiovasc Res, February 16, 2001; 49(3): 543 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nelimarkka, H. Salminen, T. Kuopio, S. Nikkari, T. Ekfors, J. Laine, L. Pelliniemi, and H. Jarvelainen Decorin Is Produced by Capillary Endothelial Cells in Inflammation-Associated Angiogenesis Am. J. Pathol., February 1, 2001; 158(2): 345 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Simons, R. O. Bonow, N. A. Chronos, D. J. Cohen, F. J. Giordano, H. K. Hammond, R. J. Laham, W. Li, M. Pike, F. W. Sellke, et al. Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus : An Expert Panel Summary Circulation, September 12, 2000; 102 (11): e73 - e86. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Simonini, M. Moscucci, D. W. M. Muller, E. R. Bates, F. D. Pagani, M. D. Burdick, and R. M. Strieter IL-8 Is an Angiogenic Factor in Human Coronary Atherectomy Tissue Circulation, April 4, 2000; 101(13): 1519 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Moussa and J. W. Moses Angiogenesis for Treatment of Ischemic Heart Disease: Should We Worry About Progression of Atherosclerosis? Circulation, November 30, 1999; 100 (22): e109 - e109. [Full Text] [PDF] |
||||
![]() |
M. Fleisch, M. Billinger, F. R. Eberli, A. R. Garachemani, B. Meier, and C. Seiler Physiologically Assessed Coronary Collateral Flow and Intracoronary Growth Factor Concentrations in Patients With 1- to 3-Vessel Coronary Artery Disease Circulation, November 9, 1999; 100(19): 1945 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Walter and D. C. Sane Angiostatin Binds to Smooth Muscle Cells in the Coronary Artery and Inhibits Smooth Muscle Cell Proliferation and Migration In Vitro Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2041 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Kroon, P. Koolwijk, H. van Goor, U. H. Weidle, A. Collen, G. van der Pluijm, and V. W. M. van Hinsbergh Role and Localization of Urokinase Receptor in the Formation of New Microvascular Structures in Fibrin Matrices Am. J. Pathol., June 1, 1999; 154(6): 1731 - 1742. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Moulton, E. Heller, M. A. Konerding, E. Flynn, W. Palinski, and J. Folkman Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice Circulation, April 6, 1999; 99(13): 1726 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Babic, C.-C. Chen, and L. F. Lau Fisp12/Mouse Connective Tissue Growth Factor Mediates Endothelial Cell Adhesion and Migration through Integrin alpha vbeta 3, Promotes Endothelial Cell Survival, and Induces Angiogenesis In Vivo Mol. Cell. Biol., April 1, 1999; 19(4): 2958 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pels, M. Labinaz, C. Hoffert, and E. R. O'Brien Adventitial Angiogenesis Early After Coronary Angioplasty : Correlation With Arterial Remodeling Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 229 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Chen, Y. Nakashima, K. Tanaka, S. Shiraishi, K. Nakagawa, and K. Sueishi Immunohistochemical Expression of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Atherosclerotic Intimas of Human Coronary Arteries Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 131 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, H. Itoh, M. Ueda, T. Naruko, A. Kojima, R. Komatsu, K. Doi, Y. Ogawa, N. Tamura, K. Takaya, et al. Vascular Endothelial Growth Factor (VEGF) Expression in Human Coronary Atherosclerotic Lesions : Possible Pathophysiological Significance of VEGF in Progression of Atherosclerosis Circulation, November 17, 1998; 98(20): 2108 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Rekhter, G. W. Hicks, D. W. Brammer, C. W. Work, J.-S. Kim, D. Gordon, J. A. Keiser, and M. J. Ryan Animal Model That Mimics Atherosclerotic Plaque Rupture Circ. Res., October 5, 1998; 83(7): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Arkonac, L. C. Foster, N. E. S. Sibinga, C. Patterson, K. Lai, J.-C. Tsai, M.-E. Lee, M. A. Perrella, and E. Haber Vascular Endothelial Growth Factor Induces Heparin-binding Epidermal Growth Factor-like Growth Factor in Vascular Endothelial Cells J. Biol. Chem., February 20, 1998; 273(8): 4400 - 4405. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Waltenberger Modulation of Growth Factor Action : Implications for the Treatment of Cardiovascular Diseases Circulation, December 2, 1997; 96(11): 4083 - 4094. [Abstract] [Full Text] |
||||
![]() |
R. Brandl, T. Richter, K. Haug, M. G. Wilhelm, P. C. Maurer, and W. Nathrath Topographic Analysis of Proliferative Activity in Carotid Endarterectomy Specimens by Immunocytochemical Detection of the Cell Cycle–Related Antigen Ki-67 Circulation, November 18, 1997; 96(10): 3360 - 3368. [Abstract] [Full Text] |
||||
![]() |
D. S. Winlaw Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases Ann. Thorac. Surg., October 1, 1997; 64(4): 1204 - 1211. [Abstract] [Full Text] |
||||
![]() |
D. P. Hajjar and M. E. Haberland Lipoprotein Trafficking in Vascular Cells. MOLECULAR TROJAN HORSES AND CELLULAR SABOTEURS J. Biol. Chem., September 12, 1997; 272(37): 22975 - 22978. [Full Text] [PDF] |
||||
![]() |
J. Ruef, Z. Y. Hu, L.-Y. Yin, Y. Wu, S. R. Hanson, A. B. Kelly, L. A. Harker, G. N. Rao, M. S. Runge, and C. Patterson Induction of Vascular Endothelial Growth Factor in Balloon-Injured Baboon Arteries : A Novel Role for Reactive Oxygen Species in Atherosclerosis Circ. Res., July 19, 1997; 81(1): 24 - 33. [Abstract] [Full Text] |
||||
![]() |
H. Abedi and I. Zachary Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells J. Biol. Chem., June 13, 1997; 272(24): 15442 - 15451. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Klauber, F. Browne, B. Anand-Apte, and R. J. D'Amato New Activity of Spironolactone: Inhibition of Angiogenesis In Vitro and In Vivo Circulation, November 15, 1996; 94(10): 2566 - 2571. [Abstract] [Full Text] |
||||
![]() |
D. A. Engler Use of Vascular Endothelial Growth Factor for Therapeutic Angiogenesis Circulation, October 1, 1996; 94(7): 1496 - 1498. [Full Text] |
||||
![]() |
N. Wang, I. Tabas, R. Winchester, S. Ravalli, L. E. Rabbani, and A. Tall Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma J. Biol. Chem., April 12, 1996; 271(15): 8837 - 8842. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Guyton and K. F. Klemp Development of the Lipid-Rich Core in Human Atherosclerosis Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 4 - 11. [Full Text] |
||||
![]() |
J. Folkman Clinical Applications of Research on Angiogenesis N. Engl. J. Med., December 28, 1995; 333(26): 1757 - 1763. [Full Text] [PDF] |
||||
![]() |
M. Hoshiga, C. E. Alpers, L. L. Smith, C. M. Giachelli, and S. M. Schwartz {alpha}vß3 Integrin Expression in Normal and Atherosclerotic Artery Circ. Res., December 1, 1995; 77(6): 1129 - 1135. [Abstract] [Full Text] |
||||
![]() |
S. M. Schwartz, D. deBlois, and E. R. M. O'Brien The Intima : Soil for Atherosclerosis and Restenosis Circ. Res., September 1, 1995; 77(3): 445 - 465. [Full Text] |
||||
![]() |
S. M. Dallabrida, M. A. De Sousa, and D. H. Farrell Expression of Antisense to Integrin Subunit beta 3 Inhibits Microvascular Endothelial Cell Capillary Tube Formation in Fibrin J. Biol. Chem., October 6, 2000; 275(41): 32281 - 32288. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vincent, C. Soria, F. Mirshahi, P. Opolon, Z. Mishal, J.-P. Vannier, J. Soria, and L. Hong Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 623 - 629. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |